Your browser is no longer supported. Please, upgrade your browser.
SOLY Soliton, Inc. monthly Stock Chart
Soliton, Inc.
Index- P/E- EPS (ttm)-1.05 Insider Own5.50% Shs Outstand16.48M Perf Week-11.73%
Market Cap235.66M Forward P/E- EPS next Y- Insider Trans- Shs Float5.18M Perf Month35.67%
Income-12.60M PEG- EPS next Q- Inst Own0.90% Short Float4.96% Perf Quarter121.02%
Sales- P/S- EPS this Y-29.10% Inst Trans- Short Ratio0.20 Perf Half Y-
Book/sh0.57 P/B25.09 EPS next Y- ROA-468.80% Target Price- Perf Year-
Cash/sh0.30 P/C48.09 EPS next 5Y- ROE106.50% 52W Range4.12 - 29.00 Perf YTD193.63%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-44.55% Beta-
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin- 52W Low290.29% ATR2.81
Employees7 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)54.32 Volatility10.75% 28.29%
OptionableNo Debt/Eq0.00 EPS Q/Q52.60% Profit Margin- Rel Volume1.34 Prev Close14.30
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.31M Price16.08
Recom- SMA2017.67% SMA5027.30% SMA20059.54% Volume980,807 Change12.45%
Jun-17-19 09:15AM  Soliton Announces $9.45 Million Private Placement PR Newswire +12.45%
Jun-12-19 08:30AM  Soliton Announces Long-Term Cellulite Trial Results to be Presented at The Aesthetics Show on July 11-14, 2019 PR Newswire -10.40%
Jun-11-19 08:30AM  Soliton Confirms Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance for Today at 4:30 PM ET PR Newswire
Jun-05-19 08:00AM  Soliton Announces Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance PR Newswire -6.00%
Jun-04-19 08:00AM  Soliton Announces Significant Discovery of Acoustic Subcision for Treatment of Cellulite PR Newswire +22.05%
May-30-19 04:26PM  Why Soliton's Shares Went on a Roller Coaster Ride Today Motley Fool -7.79%
May-29-19 12:06PM  Soliton Tattoo Removal Device: SOLY Stock Skyrockets on FDA Approval InvestorPlace +42.62%
10:39AM  Companies to Watch: Canada Goose misses, Intel unveils new chips, Soliton soars on FDA approval Yahoo Finance
10:30AM  Medtech Firm Extends 300% Surge on Cellulite, Tattoo Device Hope Bloomberg
10:00AM  Stock Market Tumbles At Open, Breaks Below Key Levels Investor's Business Daily
09:33AM  Soliton Soars a Second Day After FDA Approves Tattoo Removal Device
08:00AM  Soliton to Initiate Pivotal Cellulite Trial after Positive Proof-of-Concept Trial Results with 20-47% Improvement in Cellulite Severity Score PR Newswire
07:29AM  Dow Jones Futures Fall: Stock Market Correction Poised To Hit New Lows Investor's Business Daily
May-28-19 05:27PM  Stocks making the biggest moves after hours: Workday, Inovio and more CNBC +148.17%
12:45PM  Soliton Rallies On FDA Approval For Tattoo Removal Device Benzinga
10:19AM  Soliton Receives FDA 510(k) Clearance of its Acoustic Shockwave RAP Device PR Newswire
May-17-19 11:57AM  Soliton Responds To Blog Calling It A 'PR Machine' Benzinga
08:00AM  Soliton Provides FDA Update and Addresses Recent Anonymous Article PR Newswire
May-16-19 08:00AM  Soliton's RAP Device Able to Penetrate Vacuole Shielding; Targets $4 Billion Potential Tattoo Removal Market PR Newswire -31.50%
May-14-19 02:39PM  Biotech Brief: Most Recent Technological Advancements Pushing U.S. Medical Device Market to New Levels PR Newswire -6.94%
08:30AM  Soliton Receives Approval for New Patent for its Acoustic Shockwave Technology PR Newswire
May-13-19 05:05PM  Fighting cellulite and removing tattoos with sound waves Yahoo Finance Video -16.25%
10:31AM  Global market to combat cellulite to reach $1.4B by 2026 Yahoo Finance Video
May-09-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire +6.76%
May-01-19 08:00AM  Soliton Announces Completion of New Replaceable Cartridge to Target Cellulite Reduction PR Newswire +6.73%
Apr-23-19 08:00AM  Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction PR Newswire +11.64%
Apr-18-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire -9.99%
Apr-15-19 08:00AM  Soliton Announces Cellulite Trial Results to be Presented at National Aesthetics Conference on May 11, 2019 PR Newswire +14.55%
Apr-09-19 08:00AM  Soliton Completes Cellulite Clinical Trials PR Newswire
Apr-04-19 08:00AM  Soliton Receives European Patent for Acoustic Shockwave Technology PR Newswire +11.11%
Apr-01-19 08:00AM  Soliton Initiated Clinical Trials for Treatment of Cellulite in Humans PR Newswire +10.74%
Mar-27-19 08:00AM  Soliton Receives FDA Acceptance for 510(k) Application PR Newswire
Mar-21-19 08:00AM  Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device PR Newswire +8.16%
Mar-19-19 08:00AM  Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication PR Newswire +17.55%
Mar-18-19 08:00AM  Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-14-19 08:00AM  Soliton Partners with Sanmina, a Global Medical Device Manufacturer ACCESSWIRE +10.00%
Mar-12-19 08:00AM  Soliton to Ring the Nasdaq Stock Market Closing Bell on March 19, 2019 ACCESSWIRE
Mar-08-19 08:00AM  Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation ACCESSWIRE
Mar-04-19 07:00AM  Soliton Receives FDA Approval for Small Business Designation ACCESSWIRE
Feb-28-19 07:00AM  Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite GlobeNewswire +6.85%
Feb-26-19 07:30AM  Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology GlobeNewswire
Feb-19-19 12:03PM  Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol SOLY GlobeNewswire
Soliton, Inc., an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.